Demand for Gilead’s remdesivir has been growing given the lack of approved treatments or vaccines for COVID-19.
218 COVID-19 cases have been diagnosed in the past 24 hours in Armenia, the National Center for Disease Control and Prevention reported. The total cumulative number of infection cases has reached 5041.
